New allergy shot for teens enters early testing
NCT ID NCT07513857
First seen Apr 22, 2026 · Last updated May 20, 2026 · Updated 5 times
Summary
This study tests a new injection called JYB1904 in 12 teenagers aged 12-17 with allergic diseases like food allergies, hay fever, asthma, or hives. The main goal is to check if the drug is safe and how the body processes it. This is an early-phase trial, so it focuses on safety and dosing, not on curing the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.